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Abstract
Background—Inflammatory Bowel Disease (IBD) and abdominal pain of functional origin (AP) 
are common gastrointestinal disorders in children that are associated with increased risk for 
depression and disability. Both symptom severity and coping with symptoms may contribute to 
these outcomes. We hypothesized that children with AP use different coping strategies compared 
to those with IBD for a number of reasons, including the fact that fewer treatment options are 
available to them. We also examined if coping was related to depression and functional disability 
beyond the contributions of symptom severity.
Methods—Secondary data analysis of two existing datasets including 200 children with AP 
(73% girls; mean age 11.2) and 189 children with IBD (49% girls; mean age 13.8).
Results—Compared to IBD patients, AP patients reported more use of coping strategies of self-
isolation, behavioral disengagement, and catastrophizing as well as problem-solving and seeking 
social support. Multivariate analyses revealed that, in both samples, one or more coping strategies 
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were associated with depression and functional disability, independent of symptom severity, and 
controlling for age and gender. In IBD, symptoms were not a significant predictor of depression, 
but coping was. Catastrophizing predicted depression and disability in both samples.
Conclusion—AP patients report more frequent use of several of the coping strategies we 
measured compared to IBD patients. Certain types of coping, particularly catastrophizing, were 
associated with greater depression and functional disability in both groups. Clinicians should be 
aware of maladaptive coping, which may be a risk factor for poor psychosocial and functional 
outcomes in both patient groups.
Keywords
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Introduction
Pediatric chronic gastrointestinal disorders are associated with significant medical and 
psychosocial sequelae. Two common gastrointestinal disorders encountered among children 
and adolescents in tertiary care are Inflammatory Bowel Disease (IBD) and abdominal pain 
of functional origin (AP). AP may include several disorders such as Irritable Bowel 
Syndrome, Functional Dyspepsia, Abdominal Migraine, and Functional Abdominal Pain1. 
In this paper we will use the term abdominal pain of functional origin (AP) to include all of 
these disorders. AP is characterized by idiopathic pain without clear associated 
pathophysiology, unlike IBD, in which documented pathology is present. Despite 
differences in pathophysiology, both IBD and AP are chronic disorders characterized by 
waxing and waning of symptoms, and both carry an increased risk for negative psychosocial 
outcomes such as depression, disability and decreased quality of life2-4.
However, these negative outcomes are not universal. Only a subgroup of these children 
suffer from clinically significant depression, and many children are able to continue to 
attend school and other social activities5, 6. Being able to differentiate children who are at 
risk for poor functional and psychosocial adjustment from those who are not is therefore of 
critical importance. While symptom severity is likely to be associated with outcomes, it does 
not appear to be the sole or most important factor. For example, in a sample of children with 
IBD, neither past nor current disease severity was associated with depression, anxiety, or 
social functioning5. Thus, factors other than disease severity likely play a role in 
psychosocial and functional outcomes of IBD and AP.
One such factor may be how the child copes with their gastrointestinal (GI) symptoms. 
Coping can be defined as purposeful efforts to manage stressful events or experiences7. The 
symptoms associated with a chronic GI disorder pose challenges that can affect quality of 
life and other psychosocial outcomes. Those challenges may increase with the severity of 
symptoms, requiring greater coping efforts to manage successfully. Consistent with this, in 
adults with Irritable Bowel Syndrome and IBD, coping efforts (with stressful events in 
general, not specific to GI symptoms) were higher in those with more severe symptoms8. 
However, the relative importance of symptom severity versus coping for outcomes in 
van Tilburg et al. Page 2













children with IBD and AP is unclear. In a study among adults with IBD, pain was more 
important than coping with pain in predicting quality of life, while in patients with 
abdominal pain of functional origin, pain coping was more important than pain in predicting 
outcomes9. One study reported associations between social functioning and both disease 
severity and coping with general stressors (not disease specific) in adolescents with IBD10. 
Thus examining both coping and symptom severity in relation to outcomes is important in 
resolving this question.
Coping with GI symptoms may take many different forms such as support-seeking, 
problem-solving, escape and distraction11. Some of these coping strategies may be helpful in 
dealing with GI symptoms while others are not. For example, catastrophizing - a tendency to 
magnify the seriousness of symptoms while feeling helpless to change symptoms - has been 
associated with worse outcomes in both children with AP and IBD12-14. It could be 
hypothesized that coping with symptoms may differ between patients with AP compared to 
IBD, because of the difference in pathophysiology and treatment. IBD patients know the 
cause of their symptoms and have multiple treatments available to reduce symptoms; using 
these treatment options may be considered a form of problem-solving coping. For AP 
patients, on the other hand, both the cause of the pain and effective treatments often remain 
elusive. Therefore, because the child with AP does not have a definitive explanation for the 
source of his/her pain and thus would logically perceive s/he has fewer options to reduce the 
symptoms directly, the child may be less likely to use problem-focused coping strategies and 
more likely to worry about symptoms becoming worse (catastrophizing). However, that 
possibility may be complicated by the fact that like AP, IBD can also be unpredictable, even 
when treatment guidelines are observed. Children with IBD may experience symptoms such 
as abdominal pain, diarrhea and bloating even during episodes of remission, and may 
similarly feel a loss of control over symptoms worsening unpredictably. Therefore, it 
remains to be determined if there are differences in the use of coping strategies in children 
with these distinct types of gastrointestinal disorders, which have different courses, 
treatments, and implications for health status. While there is some evidence that coping may 
be linked with psychosocial outcomes in children with AP, it is not clear if the same coping 
strategies predict depression and disability in pediatric IBD patients. Such investigations are 
important as they may help us understand adaptation and functioning in children dealing 
with chronic gastrointestinal symptoms irrespective of etiology. A better understanding of 
strategies used and their relationship to outcomes could be helpful in identifying children at 
risk for poor adjustment to chronic gastrointestinal problems and in identifying targets and 
strategies for clinical intervention.
Accordingly, the aim of the current study is to examine and compare the relation of GI 
symptom severity and child coping with GI symptoms to psychosocial outcomes in both 
IBD and AP patients. We hypothesize that: (1) Children with AP and IBD will differ in the 
type of coping strategies they frequently use to manage their symptoms; and (2) Similar 
maladaptive coping strategies will be associated with depression and disability in both IBD 
and AP after controlling for GI symptom severity.
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This is a secondary data analysis of two existing datasets. The data consist of cross-sectional 
baseline data collected for two multi-site trials of cognitive behavioral therapy for pediatric 
IBD and pediatric AP15, 16. The trials for IBD and AP were similar in design and treatment 
content, and were conducted by the same research team. The studies were approved by the 
Institutional Review Boards of Seattle Children's Hospital, Mary Bridge Children's Hospital 
(Tacoma, WA) and Goryeb Children's Hospital (Morristown, NJ).
Participants
Participants were children aged 7-18 years old recruited from pediatric gastroenterology 
clinics with a diagnosis of IBD for at least 3 months, or a diagnosis of AP (≥3 episodes of 
abdominal pain severe enough to interfere with normal activities in the past 3 months). 
Exclusion criteria included the presence of another chronic disease explaining 
gastrointestinal symptoms, major surgery in the past year (unrelated to IBD), developmental 
disability impairing the ability to complete assessment or treatment, and non-English 
speaking ability. Lactose intolerance was also an exclusion criterion for AP children. The 
recruitment period was from 2005-2009 for the AP study and 2008-2012 for the IBD study. 
Further details on specific inclusion and exclusion criteria for each sample and methods of 
participant recruitment can be found in Levy et al15 and Langer et al16.
Child-reported measures
All children completed a battery of questionnaires by telephone with an interviewer who 
was blinded to the study aims and randomized treatment condition. Questionnaires were 
completed at baseline before the start of treatment. We focus here on the following 
assessments:
Coping—Coping was measured with the Pain Response Inventory (PRI)17 which assesses 
coping with stomachaches (AP) or stomach problems (IBD). The PRI consists of 11 coping 
subscales which can be divided in three higher order scales (active, passive and 
accommodative coping). Passive and active coping subscales, rather than accommodative 
coping, have been shown to be associated with disability and depression in AP patients18-20. 
Therefore, only passive and active coping subscales were included in the current study. 
Passive coping scales included: Catastrophizing (5 items such as “Think to yourself that it 
will never stop”), Self-Isolation (5 items such as “Try to be alone”), and Behavioral 
Disengagement (5 items such as ‘Give up trying to feel better”). Active coping subscales 
include: Problem Solving (5 items such as “Try to think of a way that you could make it 
better”), Seeking Social Support (6 items such as “Talk to someone who will understand 
how you feel”), Rest (5 items such as “Try to rest”) and Massage/Guard (2 items such as 
“Rub your stomach to try to make it better”). All items were answered on a 0-4 scale 
ranging from “Never” to “Always”. All items for each subscale were summed and averaged 
to obtain a mean subscale score (0-4).
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GI symptom severity—IBD symptoms were measured via the Inflammatory Bowel 
Disease Symptom Questionnaire (IBDS)21. The IBDS assesses 11 common symptoms of 
IBD including pain, diarrhea, eye disease, bleeding, fever, vomiting, pain/swelling of joints, 
skin disease, loss of bowel control, bloating/gas, and frequent trips to the bathroom, each 
rated on a 6 point scale from ‘no symptoms’ to ‘very severe’. All individual items were 
summed to obtain a total score (0-55). The IBDS has adequate internal consistency and is a 
good predictor of health status in adult IBD patients21, but has not been psychometrically 
evaluated in children. In our study we found satisfactory internal consistency (Cronbach 
alpha = 0.74) for this measure. We also found significant associations between the IBD 
symptom scale and the Pediatric Crohn's Disease Activity Index22 (r=0.32, P<.001) and 
Pediatric Ulcerative Colitis Activity Index23 (r=0.41, p<.001) providing preliminary 
evidence of validity.
AP symptoms were measured with the gastrointestinal symptom severity subscale of the 
Children's Somatization Inventory. The Children's Somatization Inventory24, 25 is a reliable 
and valid measure of children's somatic symptoms. It contains 7 items assessing how much 
the child is bothered by gastrointestinal symptoms (nausea, constipation, diarrhea, 
abdominal pain, vomiting, bloating and food making you sick). Items are answered on a 0- 
to 4-point scale (“not at all” to “a whole lot”). All items were summed to obtain a total score 
(0-28).
Disability—Disability was assessed with the Functional Disability Inventory (FDI)26, 27. 
The FDI is a well-validated questionnaire assessing children's self-reported difficulty in 
functioning in the past two weeks due to their physical health. The FDI consists of 15 items 
such as “In the last week would your child have any physical trouble or difficulty being at 
school all day” and responses range from no trouble (0) to impossible (4). Total scores were 
computed by summing the item scores (0-60). Higher values indicate greater disability.
Depression—Depressive symptoms were measured with the Children's Depression 
Inventory (CDI)28, 29 a well-validated questionnaire. The CDI consists of 27-item 
questionnaire rated on a 3-point scale (from 0 to 2); the one item about suicidal ideation was 
omitted. Total scores were computed by summing the items (0-52).
Data analysis
Independent t-tests and Chi Square tests were conducted to examine possible differences in 
age and gender between the IBD and AP samples. Given that age and gender differences 
were found (see Table 1), all subsequent analyses were conducted controlling for these 
variables. Differences in coping strategies between IBD and AP were examined using 
ANCOVA with age and gender as covariates. Other analyses were conducted separately for 
the AP and IBD samples. Linear regression analysis was used to examine if coping and GI 
severity (independent variables) were associated with higher levels of depression and 
disability (dependent variables) while controlling for age and gender (independent 
variables). Separate linear regressions were run for each dependent variable.
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The sample consisted of 200 AP patients and 189 IBD patients. Demographic characteristics 
are depicted in Table 1. As mentioned previously, the AP and IBD samples differed 
significantly on child gender and child age. Compared to AP, the IBD sample was somewhat 
older and included a higher percentage of boys. Controlling for age and gender, AP patients 
reported higher levels of depression and disability compared to IBD patients (see Table 2).
Coping differences between IBD and AP
As hypothesized, children with AP and IBD differed in their use of coping strategies (see 
Table 2). Compared to IBD, AP patients scored higher on all forms of coping, both adaptive 
and maladaptive, except social support and massage/guard.
The relation between coping strategies and depression
Separate linear regression analyses were conducted for children with AP and IBD. In both 
models, GI symptom severity and child coping were entered as independent variables 
predicting depression, while controlling for age and gender. This model was significant in 
both the IBD (F=16.5, p<0.001, R2= 0.48) and AP samples (F=13.4, p<0.001, R2= 0.43). As 
can be seen in Table 3, in the IBD sample, child-reported catastrophizing, behavioral 
disengagement, and social isolation were positively associated with depression whereas 
seeking social support was negatively associated with depression. Symptom severity did not 
significantly relate to depression in the IBD group. In the AP sample, GI symptom severity 
and catastrophizing were significantly positively associated with depression while seeking 
social support was negatively associated with depression (see Table 4). Rest, problem 
solving and massage/guard were not associated with depression in either sample.
The relation between coping strategies and functional disability
As with depression, separate analyses were conducted for the AP and IBD samples. 
Symptom severity and child coping were entered in a linear regression predicting functional 
disability, while controlling for age and gender. The model was significant in both the IBD 
(F=20.9, p<0.001, R2= 0.54) and AP samples (F=12.06, p<0.001, R2= 0.40). Symptom 
severity and catastrophizing were positively associated with disability in the IBD sample 
(see Table 3), while in the AP sample symptom severity and rest were positively associated 
with disability while catastrophizing showed a trend towards significance (see Table 4).
Discussion
The aim of the current study was to examine coping with GI symptoms and its relationship 
to psychosocial outcomes in two gastrointestinal disorders: abdominal pain of functional 
origin (AP) and Inflammatory Bowel Disease (IBD). We hypothesized that: (1) Children 
with AP and IBD differ in the type of coping strategies they use to deal with their 
symptoms; and (2) Similar maladaptive coping will be associated with depression and 
disability in both IBD and AP after controlling for GI symptom severity. The first 
hypothesis was partially supported. Children in the AP sample reported significantly higher 
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use of catastrophizing, behavioral disengagement, and self-isolation as well as seeking social 
support and problem- solving to deal with their symptoms compared to those in the IBD 
sample. There was no significant difference in the use of rest or massage/guard, and there 
were no coping strategies that were used more frequently by the IBD group compared to the 
AP group. Thus, the AP children reported higher levels of adaptive and maladaptive coping 
but there was not a unique pattern of coping styles that differentiated the two groups.
Prior studies with adults have yielded conflicting findings on the use of coping in Irritable 
Bowel Syndrome patients (IBS - a disorder very closely related to AP in children) compared 
to those with IBD. In one study, higher levels of pain catastrophizing were reported in IBS 
patients compared to those with IBD9, but two other studies reported no differences in types 
of coping with general stressors or pain between patients with IBD and Irritable Bowel 
Syndrome8, 30. Further research to investigate the nature of coping in patients with IBD 
versus those with IBS or AP is needed to resolve this question.
We found support for our second hypothesis. In the regression analyses predicting outcomes 
within each diagnostic group, maladaptive coping with GI symptoms was associated with 
both depression and disability after controlling for symptom severity in both groups. Coping 
predicted equal or more variance than disease symptom severity (33% vs 15% in the IBD 
group and 25% vs 25% in the AP group) for depressive symptoms. In fact, symptom 
severity was not significantly associated with symptoms of depression in the IBD sample. 
This finding emphasizes the importance of coping with symptoms in predicting psychosocial 
outcomes of gastrointestinal disorders. Although this finding could be due to the relatively 
low levels of depressive and GI symptoms reported in this IBD sample as a whole, when we 
restricted the analysis to IBD patients with scores suggestive of clinical depression (above 
11; n=51), or those scoring in the top 25% in IBD symptom severity (n=48), the findings did 
not change, and symptom severity did not predict outcomes. Of course, this analysis of a 
subsample is not conclusive given the restricted range of the outcome variables and smaller 
sample size, but it supports the role that coping may play in depression and disability. Larger 
samples of IBD patients with a wider range of scores on severity of disability and depression 
are needed to confirm these preliminary findings.
Child catastrophizing consistently predicted depression as well as disability (with a trend for 
disability in the AP sample). In fact, catastrophizing was the only coping strategy related to 
disability in the IBD sample. Catastrophizing is marked by a tendency to magnify the 
negative or threatening aspects of the symptoms, and to appraise it as beyond one's ability to 
cope. Catastrophizing has been established as an important factor predicting psychosocial 
outcomes in AP14, 31 but is not well studied in pediatric IBD. Results of a recent study 
showed that both pain catastrophizing and abdominal pain severity predicted disability in 
pediatric IBD patients32. In an adult sample of IBD patients, Morrison and colleagues33 
observed that pain catastrophizing was an important predictor of disability. Similarly, pain 
catastrophizing has been reported to be associated with poor quality of life in adult IBD 
patients9. These findings, combined with the current observations, establish the importance 
of catastrophizing in IBD and warrant more research on this construct in children and 
adolescents with IBD.
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Depressive symptoms were also associated with child self-isolation, less seeking of social 
support, and behavioral disengagement (the latter in the IBD sample only). A hallmark 
symptom of depression is behavioral withdrawal34 marked by isolation and passivity. 
Therefore, it comes as no surprise that self-isolation and behavioral disengagement are 
associated with increased depression while actively seeking support is associated with 
decreased depression. These findings may indicate that children who struggle with a chronic 
gastrointestinal disorder, no matter the cause, isolate themselves from friends and activities, 
possibly due to the unpredictability and potentially embarrassing nature of their symptoms.
A strength of this study is the inclusion of a large sample of both IBD and AP patients; 
nonetheless, there are several limitations to the study that should be noted. First, the 
correlational design does not allow for a cause and effect examination. We do not know if 
coping with symptoms influences depression and disability or vice versa, or if the 
relationship is bidirectional, which may be likely. Longitudinal studies are needed to 
examine these effects in a prospective design. However, there is evidence that interventions 
to reduce catastrophizing are associated with pain reductions in AP 15, 35, suggesting that 
changes in some types of coping may affect AP outcomes. A second limitation is that the 
data were collected from the IBD and AP cohorts at different time periods (recruitment 
periods overlapped by one year) and in different studies. However, the data were collected 
by the same group of researchers recruiting from some of the same medical centers, in the 
context of similar treatment studies employing similar assessment methods. This increases 
the confidence that the two datasets can be compared, keeping in mind the caveats noted 
above. A third limitation is related to the fact that coping may change with duration of the 
disease. One study found that children with IBD did not differ from their healthy peers in 
coping with general stressful situations and psychosocial functioning a year after diagnosis5. 
This may suggest changes in these variables happen over time. However, it may also have 
been the case that this was a different sample of patients in comparison to other studies. 
Information on disease duration was not available in the AP dataset. Future studies are 
needed to investigate the role of disease duration in coping and psychosocial outcomes.
Another possible limitation is that the coping questionnaire was originally developed for 
coping with pain and we adjusted it the measure coping with more general GI symptoms in 
the IBD sample. Although abdominal pain is one of the most common symptoms in IBD (in 
our sample 78% of children reported at least some abdominal pain), we changed the 
measured to ask about ‘stomach problems’ rather than only pain. It may be possible that 
coping with stomach problems differs from coping with other symptoms of IBD (e.g., eye 
problems, fever etc.), which were not included in the coping measure. However, the use of a 
symptom-specific measure may be more informative compared to the use of a general 
coping measure. Most previous studies on coping in IBD have used general coping 
questionnaires, measuring the use of coping with any stressor in the child's life, or focused 
exclusively on coping with pain36105, 37. Lastly, although we found that symptom severity 
and child coping predicted a substantial 40-54% of the variance in depression and disability, 
indicating their importance in predicting these outcomes, the level of depression and 
disability in both samples was, on average, within normal limits, and results may not 
generalize to a more depressed or disabled sample. In addition, the level of GI symptom 
severity was generally low, particularly in the IBD sample, which may have reduced the 
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contribution of symptom severity to depression and disability. Further research is needed to 
identify other contributing factors associated with important psychosocial outcomes in these 
populations, including those with more active symptomatology.
In conclusion, how a child copes with his/her symptoms is an important independent 
contributor to depression and disability above and beyond GI symptom severity in children 
with IBD and AP. Child catastrophizing in particular was linked to negative outcomes. 
Therefore, it is important for clinicians to ask about children's coping and screen for distress, 
social withdrawal, excessive worry about symptoms or other indications of poor coping as 
these may indicate an increased risk for depression and disability, suggesting consideration 
of referral for psychological interventions.
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What is known about this subject?
• Maladaptive coping in children with abdominal pain of functional origin 
predicts psychosocial outcomes.
• Symptom severity in children Inflammatory Bowel Disease does not predict 
these outcomes, but less is known about coping in this population.
• No studies to date have directly compared these two populations.
What are the new findings and what is the impact on clinical practice?
• Patients with abdominal pain of functional origin used more coping overall 
compared to Inflammatory Bowel Disease patients.
• Coping explained psychosocial outcomes independent of symptom severity. 
Catastrophizing, behavioral disengagement, and social isolation were associated 
with worse outcomes and social support with better outcomes.
• Clinicians should be aware of maladaptive coping as it may worsen outcomes 
and help identify children who could benefit from psychosocial interventions to 
teach adaptive coping skills.
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% or Mean (SD)
IBD
N=189
% or Mean (SD)
P
Gender 72.5% girls 48.7% girls <0.001










30.5% Irritable Bowel Syndrome
18.5% Functional Abdominal Pain






As determined by Rome III criteria (Parents completed the Questionnaire on Pediatric Gastrointestinal Symptoms-Rome III1). Children can 
qualify for more than one Rome III criteria and 14.5% did not qualify for any Rome III disorder based on parental report of symptoms.













van Tilburg et al. Page 14
Table 2
Differences between AP and IBD samples in child coping, depression and functional disability (all tests 
adjusted for age and gender)
Scale AP Mean(SD) IBD Mean(SD) p
Coping (0-4 score)
        Self-isolation 1.00(0.8) 0.92(0.9) 0.003
        Behavioral Disengagement 0.84(0.7) 0.60(0.7) <0.001
        Catastrophizing 1.56(0.9) 0.98(0.8) <0.001
        Problem Solving 2.49(0.8) 2.15(0.8) 0.007
        Rest 2.09(0.8) 2.02(0.8) 0.32
        Seeking Social Support 2.24(0.8) 1.77(1.0) 0.01
        Guard 1.61(1.4) 1.61(1.3) 0.82
Depression (0-36) 9.78(6.5) 8.22(7.3) 0.02
Disability (0-43) 11.32(9.0) 6.48(7.1) <.001
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